Special Series: Stem Cells and Hearing Loss

Majlinda Lako¹, Konstantina M Stankovic^{2

3

4

5

6}, Miodrag Stojkovic^{2

3

7

8}

Affiliations

¹ Newcastle University, Biosciences Institute, Newcastle upon Tyne, UK.
² Eaton Peabody Laboratories, Department of Otolaryngology Head and Neck Surgery, Massachusetts Eye and Ear, Boston, Massachusetts, USA.
³ Department of Otolaryngology Head and Neck Surgery, Harvard Medical School, Boston, Massachusetts, USA.
⁴ Program in Speech and Hearing Bioscience and Technology, Harvard University, Cambridge, Massachusetts, USA.
⁵ Harvard Program in Therapeutic Science, Harvard Medical School, Boston, Massachusetts, USA.
⁶ Harvard Stem Cell Institute, Cambridge, Massachusetts, USA.
⁷ Human Genetics, Faculty of Medical Sciences, University of Kragujevac, Kragujevac, Serbia.
⁸ SPEBO Medical, Leskovac, Serbia.

Editorial

Majlinda Lako et al. Stem Cells. 2021 Jul.

. 2021 Jul;39(7):835-837.

doi: 10.1002/stem.3390. Epub 2021 May 5.

Majlinda Lako¹, Konstantina M Stankovic^{2

3

4

5

6}, Miodrag Stojkovic^{2

3

7

8}

¹ Newcastle University, Biosciences Institute, Newcastle upon Tyne, UK.
² Eaton Peabody Laboratories, Department of Otolaryngology Head and Neck Surgery, Massachusetts Eye and Ear, Boston, Massachusetts, USA.
³ Department of Otolaryngology Head and Neck Surgery, Harvard Medical School, Boston, Massachusetts, USA.
⁴ Program in Speech and Hearing Bioscience and Technology, Harvard University, Cambridge, Massachusetts, USA.
⁵ Harvard Program in Therapeutic Science, Harvard Medical School, Boston, Massachusetts, USA.
⁶ Harvard Stem Cell Institute, Cambridge, Massachusetts, USA.
⁷ Human Genetics, Faculty of Medical Sciences, University of Kragujevac, Kragujevac, Serbia.
⁸ SPEBO Medical, Leskovac, Serbia.

No abstract available

References

1. Kempfle JS, Luu N-NC, Petrillo M, Al-Asad R, Zhang A, Edge ASB. Lin28 reprograms inner ear glia to a neuronal fate. Stem Cells. 2020;38(7):890-903.
1. Roccio M. Directed differentiation and direct reprogramming: applying stem cell technologies to hearing research. Stem Cells. 2021;39(4):375-388.
1. Stojkovic M, Han D, Jeong M, Stojkovic P, Stankovic KM. Human induced pluripotent stem cells and CRISPR/Cas-mediated targeted genome editing: platforms to tackle sensorineural hearing loss. Stem Cells. 2021. https://doi.org/10.1002/stem.3244. [Epub ahead of print].
1. Xia M, Chen Y, He Y, Li H, Li W. Activation of the RhoA-YAP-β-catenin signaling axis promotes the expansion of inner ear progenitor cells in 3D culture. Stem Cells. 2020;38(7):860-874.
1. Zine A, Messat Y, Fritzsch B. A human induced pluripotent stem cell-based modular platform to challenge sensorineural hearing loss. Stem Cells. 2021. https://doi.org/10.1002/stem.3346. [Epub ahead of print].